During the past decade, Progressive Clinical Research conducted 71 clinical trials. In the 10-year time frame, 71 clinical trials started and 43 clinical trials were completed, i.e. on average, 60.6% percent of trials that started reached the finish line to date. In the past 5 years, 42 clinical trials started and 31 clinical trials were completed. i.e. 73.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Progressive Clinical Research" #1 sponsor was "Pfizer" with 14 trials, followed by "Eli Lilly and Company" with 11 trials sponsored, "Incyte Corporation" with 9 trials sponsored, "Janssen Research & Development, LLC" with 8 trials sponsored and "Asana BioSciences" with 8 trials sponsored. Other sponsors include 51 different institutions and companies that sponsored additional 41 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Progressive Clinical Research" #1 collaborator was "Dermira, Inc." with 4 trials as a collaborator, "Progressive Clinical Research" with 3 trials as a collaborator, "ClinDatrix, Inc." with 2 trials as a collaborator, "Clinical Trials of Texas, Inc." with 2 trials as a collaborator and "Derm Research, PLLC" with 2 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Progressive Clinical Research" are "Atopic Dermatitis" (22 trials), "Acne Vulgaris" (12 trials), "Psoriasis" (9 trials), "Plaque Psoriasis" (8 trials) and "Dermatitis, Atopic" (7 trials). Many other conditions were trialed in "Progressive Clinical Research" in a lesser frequency.

Most popular intervention types in "Progressive Clinical Research" are "Drug" (96 trials), "Biological" (11 trials) and "Other" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (39 trials), "Vehicle" (8 trials), "Lebrikizumab" (5 trials), "Ruxolitinib cream" (5 trials) and "ASN002" (4 trials). Other intervention names were less common.

The vast majority of trials in "Progressive Clinical Research" are 103 trials for "All" genders.

Currently, there are NaN active trials in "Progressive Clinical Research". undefined are not yet recruiting, 6 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 74 completed trials in Progressive Clinical Research, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Progressive Clinical Research, 12 "Phase 1" clinical trials were conducted, 42 "Phase 2" clinical trials and 48 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".